Latest Partnerships News

Triangle Energy has initiated legal proceedings against Strike Energy's subsidiary over a $3.84 million dispute tied to the L7 permit in the Perth Basin, escalating tensions in a key oil and gas project.

Spacetalk Ltd reports robust 28% growth in active mobile subscribers and a 20% rise in annual recurring revenue, fueled by strategic international expansion and a forthcoming software-led platform upgrade.

Harvest Technology Group reported improved EBITDA and secured new customers across mining, defence, and border control sectors in Q1 FY2026, supported by $2.13 million raised through convertible notes and loans.

Nelson Resources confirms high-grade gold assay results at its Yarri Project and partners with MEGA Resources to fully fund and manage development operations.

Elixir Energy is set to resume production testing at its Diona-1 well this quarter and prepare for the high-impact Lorelle-3 appraisal well drilling in January 2026, aiming to unlock significant gas resources in Queensland’s Taroom Trough.

Scorpion Minerals Limited has resumed trading following a pivotal announcement on drilling results, a new tenement application, and a potential strategic partnership, alongside financing updates.

Scorpion Minerals reports promising shallow gold intercepts at its Pharos Project and announces a strategic collaboration with Gylden Resources, enhancing processing options in Western Australia’s Murchison region.

Ioneer Ltd has enhanced the economics of its Rhyolite Ridge Lithium-Boron Project by cutting leach retention time, boosting lithium and boron production and improving key financial metrics with minimal capital cost increase.

Associate Global Partners Limited reported a 4.6% increase in funds under management to $1.464 billion for Q3 2025, driven by robust inflows and standout returns from its WCM strategies. The company also sustained positive operating cash flows for the fourth consecutive quarter.

Eclipse Metals has advanced its Greenland rare earths project with expanded drilling and a key licence renewal, while preparing for a NASDAQ dual listing to tap North American investors.

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

CVC Limited is contemplating a fresh offer of Capital Notes, potentially including a reinvestment option for existing holders, contingent on market and regulatory conditions.